Active Share (vs S&P 500): 99.7%
· vs QQQ: 99.1%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
-14.1%
· vs SPY
-16.2%
· Prev Value $206.66M
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
-10.2%
· vs SPY
-12.4%
· Latest Value $166.47M
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, GordonMD Global Investments LP disclosed 14 equity positions with a combined reported value of $166.47M. The filing implies a focused portfolio: its ten largest positions account for 85.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were PYXS ($36.21M), KYTX ($30.74M), TEVA ($15.03M). By sector, the heaviest allocations are Health Care 100.0%. Versus the prior quarter, allocation shifted toward Health Care (+2.3pp) and away from Other (-2.3pp).
Versus the prior quarter, GordonMD Global Investments LP opened 2 new positions, trimmed 6 and fully exited 4, a turnover rate of 66.7% of positions. The portfolio's overlap with the prior quarter was 67% of names.
The largest new positions opened in Q3 2026 were TNGX ($9.02M), VNDA ($8.97M).
Of the 4 positions fully exited versus the prior quarter, the largest were RARE ($9.65M), SION ($5.98M), CRNX ($4.75M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest GordonMD Global Investments LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
GordonMD Global Investments LP is an SEC-registered 13F filer based in Beverly Hills, CA, United States. As of Q2 2026 it reported 16 US equity positions with a combined value of $206.66M. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).
Regulatory AUM (Form ADV): $322.27M as of 2026-03-26
Client mix (by RAUM): pension and profit-sharing plans 100%
Manages 4 private funds, of which 1 hedge funds
Portfolio Structure
16 positions · $206.66M reported value (Q2 2026)
Top 10 holdings = 83.9% of reported value
Largest position: KYTX (KYVERNA THERAPEUTICS INC) at 18.3%
Average position size: $12.92M
Sector Tilt
Health Care 97.7%
(classified holdings cover 98% of value)
Quarterly Activity
Q2 2026: 1 new, 4 added, 2 reduced, 1 exited
9 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-13.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.
Portfolio return-1.65%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+12.06%vs benchmark
Barra annualised vol52.8%Model estimate
Realised vol48.7%Annualised in window
Weighted beta1.21Raw exposure
Factor / specific risk37% / 63%Share of variance
Top-10 concentration100.0%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
-1.65%
Disclosed long book
QQQ synthetic benchmark
-13.72%
Liquidity-weighted constituents
Model universe, equal weight
+0.30%
Opportunity-cost reference
Excess return
+12.06%
Portfolio − benchmark
Arithmetic return sum
-0.19%
Difference vs compounded is the cross term
Weighted raw beta
1.21
Weighted holding betas
Realised volatility (annualised)
48.68%
Daily returns in window
Barra model volatility (annualised)
52.80%
Factor + specific
Factor share of variance
36.7%
Barra factors
Specific share of variance
63.3%
Stock residuals
Reported value
$26.7M
13F long US equity
2. Return attribution
The -0.19% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
-4.18%
-2174.4%
Momentum & Growth
3
-6.42%
-3342.7%
Volatility & Tail Risk
7
-2.82%
-1470.8%
Industry
12
+8.12%
4229.2%
Specific
1
+5.11%
2658.7%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Health Care
Industry
+1.00
+8.12%
+8.12%
4229.2%
Specific
Specific
—
—
+5.11%
2658.7%
Residual Volatility
Style
+1.91
+2.66%
+5.09%
2651.3%
Size
Style
-1.24
-1.83%
+2.28%
1185.8%
Non-linear Size
Style
+2.19
+0.91%
+2.00%
1041.9%
Beta
Style
+0.35
+4.85%
+1.71%
892.0%
Skewness
Style
-0.30
-4.21%
+1.28%
664.5%
Kurtosis
Style
+0.05
+6.97%
+0.37%
191.1%
Short-term Reversal
Style
+0.40
+0.79%
+0.31%
163.1%
Liquidity
Style
+0.63
+0.22%
+0.14%
71.2%
Amihud Illiquidity
Style
+1.95
-0.40%
-0.79%
-410.3%
Max Drawdown
Style
+0.46
-1.96%
-0.90%
-470.6%
Leverage (Downside Vol)
Style
+0.70
-1.82%
-1.28%
-667.2%
Growth
Style
-0.93
+1.57%
-1.45%
-756.0%
Mid Cap
Style
+1.95
-1.69%
-3.30%
-1719.0%
Turnover
Style
+0.94
-4.77%
-4.50%
-2344.0%
Momentum
Style
+1.58
-3.34%
-5.28%
-2749.6%
Historical Volatility
Style
+0.71
-12.86%
-9.09%
-4732.0%
3. Risk attribution
Annualised volatility is 52.80%; factor risk explains 36.7% of variance and specific risk 63.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
63.3%
+33.42%
33.4%
Health Care
Industry
+1.00
9.9%
+5.21%
5.2%
Residual Volatility
Style
+1.91
5.2%
+2.76%
2.8%
Mid Cap
Style
+1.95
4.9%
+2.59%
2.6%
Momentum
Style
+1.58
4.1%
+2.18%
2.2%
Size
Style
-1.24
2.8%
+1.48%
1.5%
Historical Volatility
Style
+0.71
2.4%
+1.28%
1.3%
Beta
Style
+0.35
2.4%
+1.26%
1.3%
Amihud Illiquidity
Style
+1.95
1.2%
+0.62%
0.6%
Max Drawdown
Style
+0.46
1.2%
+0.62%
0.6%
Liquidity
Style
+0.63
0.9%
+0.46%
0.5%
Turnover
Style
+0.94
0.9%
+0.46%
0.5%
Non-linear Size
Style
+2.19
0.8%
+0.41%
0.4%
Leverage (Downside Vol)
Style
+0.70
0.7%
+0.38%
0.4%
Growth
Style
-0.93
-0.7%
-0.39%
-0.4%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
-1.24
+2.10
-3.34
Non-linear Size
+2.19
+1.68
+0.51
Mid Cap
+1.95
+0.13
+1.82
Beta
+0.35
+1.29
-0.94
Momentum
+1.58
+0.72
+0.87
Short-term Reversal
+0.40
-0.64
+1.04
Residual Volatility
+1.91
-0.40
+2.31
Historical Volatility
+0.71
+0.86
-0.15
Liquidity
+0.64
+0.11
+0.52
Amihud Illiquidity
+1.95
+1.16
+0.80
Turnover
+0.94
+0.21
+0.74
Growth
-0.93
+0.58
-1.51
Leverage (Downside Vol)
+0.70
+0.14
+0.56
Skewness
-0.30
+0.24
-0.54
Kurtosis
+0.05
+0.21
-0.16
Max Drawdown
+0.46
-0.08
+0.55
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
0.0%
73.6%
+0.00%
-19.18%
+4.32%
+14.12%
-14.12%
+14.12%
Communication Services
0.0%
2.6%
+0.00%
-15.54%
+0.06%
+0.41%
-0.41%
+0.41%
Utilities
0.0%
0.8%
+0.00%
+11.58%
-0.20%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+0.00%
+15.58%
-0.24%
-0.13%
+0.13%
-0.13%
Consumer Discretionary
0.0%
8.8%
+0.00%
+5.56%
-1.66%
-0.49%
+0.49%
-0.49%
Industrials
0.0%
11.1%
+0.00%
+7.16%
-2.27%
-0.80%
+0.80%
-0.80%
Health Care
100.0%
1.7%
-2.64%
+9.16%
+22.08%
-0.20%
-11.60%
-2.80%
Total
+21.99%
+12.78%
-24.58%
+10.19%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
TNGX
TANGO THERAPEUTICS INC
Health Care
33.83%
+2.20%
+0.75%
New
TSHA
TAYSHA GENE THERAPIES INC
Health Care
23.20%
-15.81%
-3.67%
Reduce
AMGN
AMGEN INC
Health Care
22.94%
+10.48%
+2.40%
Reduce
SRRK
SCHOLAR ROCK HLDG CORP
Health Care
20.02%
-10.59%
-2.12%
Reduce
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
AMGN
Health Care
22.94%
+10.48%
+2.40%
2
TNGX
Health Care
33.83%
+2.20%
+0.75%
3
SRRK
Health Care
20.02%
-10.59%
-2.12%
4
TSHA
Health Care
23.20%
-15.81%
-3.67%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned -1.65%, versus -13.72% for the QQQ synthetic benchmark — an excess of +12.06%.
Return attribution: the largest positive style/industry contributions came from Health Care +8.12%, Residual Volatility +5.09%, Size +2.28%; the largest drags came from Historical Volatility -9.09%, Momentum -5.28%, Turnover -4.50%. Specific (stock-level) return contributed +5.11%.
Risk attribution: Barra model volatility is 52.80% annualised; factor risk explains 37% of variance and specific risk 63%. The largest factor risk sources are Health Care 9.9%, Residual Volatility 5.2%, Mid Cap 4.9%.
Style tilt: size -1.24, momentum +1.58, volatility +0.71, liquidity +0.64; the weighted raw beta is 1.21. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +21.99%, selection +12.78% and interaction -24.58%.
Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did GordonMD Global Investments LP buy in 2026-Q3?
In its 2026-Q3 13F filing, GordonMD Global Investments LP reported 14 equity positions worth $166.47M in aggregate; its largest disclosed positions were PYXS ($36.21M), KYTX ($30.74M), TEVA ($15.03M).
How large is GordonMD Global Investments LP's portfolio?
GordonMD Global Investments LP reported $166.47M of long equity holdings across 14 positions as of 2026-Q3. Top-10 holdings account for 85.7% of reported value.
What is GordonMD Global Investments LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/gordonmd-global-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>